Renal Denervation on Quality of 24-hr BP Control by Ultrasound In Resistant Hypertension

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 140 participants.

Also called NCT02918305

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 140 participants (planned count) (from the registry)
Sponsor
JIMRO Co., Ltd. (from the registry)
Registry
  • NCT NCT02918305
Other papers using this trial's data
  • Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial Hypertension research : official journal of the Japanese Society of Hypertension, 2022-02 DOI, PubMed 34654905, PMC8766280 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan, South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02918305. Randomized; double masking; primary purpose treatment. Start 2017-01 (actual); primary completion 2020-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Renal Denervation on Quality of 24-hr BP Control by Ultrasound In Resistant Hypertension
Acronym
REQUIRE
Condition
Hypertension
Condition
Vascular Diseases
Intervention (Device)
PRDS-001 Renal Denervation Ultrasound System
Intervention (Procedure)
Sham Procedure
Lead sponsor
JIMRO Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct02918305
Content hash
6c4fbd2d47042aff443b5a217adef5b1ca2b40fb7a8b5dbf809eab76f9e24c3f